Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (ADGM)

CUSIP: 00534B100

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
22,195,785
Total 13F shares
11,593,031
Share change
+791,234
Total reported value
$9,331,190
Price per share
$0.80
Number of holders
14
Value change
+$632,839
Number of buys
6
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 00534B100?
CUSIP 00534B100 identifies ADGM - Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ADGM - Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
PERCEPTIVE ADVISORS LLC
13F
Company
44%
9,812,419
$10,303,039 31 Dec 2024
13F
Affinity Asset Advisors, LLC
13F
Company
0.96%
213,235
$223,897 31 Dec 2024
13F
RTW INVESTMENTS, LP
13F
Company
0.94%
209,361
$219,829 31 Dec 2024
13F
Shaolin Capital Management LLC
13F
Company
0.89%
197,500
$207,374 31 Dec 2024
13F
Opaleye Management Inc.
13F
Company
0.5%
110,571
$116,100 31 Dec 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.45%
100,000
$105,000 31 Dec 2024
13F
ADAR1 Capital Management, LLC
13F
Company
0.35%
76,757
$80,595 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.1%
22,752
$23,888 31 Dec 2024
13F
XTX Topco Ltd
13F
Company
0.1%
21,180
$22,239 31 Dec 2024
13F
TORONTO DOMINION BANK
13F
Company
0.09%
20,000
$21,000 31 Dec 2024
13F
Virtu Financial LLC
13F
Company
0.05%
12,120
$13,000 31 Dec 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.02%
4,454
$4,676 31 Dec 2024
13F
UBS Group AG
13F
Company
0.01%
1,409
$1,479 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
29
$30 31 Dec 2024
13F
SBI Securities Co., Ltd.
13F
Company
0%
10
$11 31 Dec 2024
13F
James L. Cox
3/4/5
Director
mixed-class rows
400,698
mixed-class rows
20 Mar 2025
Orly Mishan
3/4/5
Director
class O/S missing
300,000
20 Mar 2025
Olav Bergheim
3/4/5
CEO, Director
class O/S missing
234,134
31 Jul 2024
Keyvan Mirsaeedi-Farahani
3/4/5
Director
class O/S missing
90,000
20 Mar 2025
Sandra A. Gardiner
3/4/5
Director
class O/S missing
90,000
20 Mar 2025
Timothy P. Moran
3/4/5
Director
class O/S missing
90,000
20 Mar 2025
Hakon Bergheim
3/4/5
Chief Operating Officer
mixed-class rows
8,539
mixed-class rows
31 Jul 2024

Institutional Holders of Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (ADGM) as of Q1 2025

As of 31 Mar 2025, Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (ADGM) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,593,031 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Shaolin Capital Management LLC, Affinity Asset Advisors, LLC, RTW INVESTMENTS, LP, Opaleye Management Inc., JPMORGAN CHASE & CO, ADAR1 Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, and TORONTO DOMINION BANK. This page lists 15 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
15
Q1 2025 holders
14
Holder diff
-1
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .